PL367817A1 - Sposób wytwarzania heksahydro-furo [2,3-b] furan-3-olu - Google Patents

Sposób wytwarzania heksahydro-furo [2,3-b] furan-3-olu

Info

Publication number: PL367817A1
Authority: PL; Poland
Prior art keywords: furo; hexahydro; furan; preparation
Prior art date: 2001-09-10

Application number

PL02367817A

Other languages

English (en)

Other versions

PL224030B1 (pl

Inventor

Bart Rudolf Romanie Kesteleyn

Dominique Louis Nestor Ghislain Surleraux

Peter Jan Leonard Mario Quaedflieg

Original Assignee

Tibotec Pharmaceuticals Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-10

Filing date

2002-09-06

Publication date

2005-03-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL367817(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-06 Application filed by Tibotec Pharmaceuticals Ltd. filed Critical Tibotec Pharmaceuticals Ltd.

2005-03-07 Publication of PL367817A1 publication Critical patent/PL367817A1/pl

2016-11-30 Publication of PL224030B1 publication Critical patent/PL224030B1/pl

Links

RCDXYCHYMULCDZ-UHFFFAOYSA-N 2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-ol Chemical compound O1CCC2C(O)COC21 RCDXYCHYMULCDZ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Furan Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL367817A 2001-09-10 2002-09-06 Sposób syntezy heksahydrofuro [2,3-b] furan -3-olu oraz związki pośrednie stosowane w tym sposobie PL224030B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01203416		2001-09-10
PCT/EP2002/010062 WO2003022853A1 (en)	2001-09-10	2002-09-06	Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Publications (2)

Publication Number	Publication Date
PL367817A1 true PL367817A1 (pl)	2005-03-07
PL224030B1 PL224030B1 (pl)	2016-11-30

Family

ID=8180908

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL367817A PL224030B1 (pl)	2001-09-10	2002-09-06	Sposób syntezy heksahydrofuro [2,3-b] furan -3-olu oraz związki pośrednie stosowane w tym sposobie

Country Status (27)

Country	Link
US (1)	US7126015B2 (pl)
EP (1)	EP1448567B1 (pl)
JP (1)	JP4521185B2 (pl)
KR (1)	KR100894673B1 (pl)
CN (2)	CN100519561C (pl)
AP (1)	AP1758A (pl)
AR (1)	AR036501A1 (pl)
AT (1)	ATE453648T1 (pl)
AU (1)	AU2002333809C1 (pl)
BR (1)	BRPI0212341B8 (pl)
CA (1)	CA2459168C (pl)
CY (1)	CY1109974T1 (pl)
DE (1)	DE60234952D1 (pl)
DK (1)	DK1448567T3 (pl)
EA (1)	EA010883B1 (pl)
ES (1)	ES2338538T3 (pl)
HR (1)	HRP20040320B1 (pl)
HU (1)	HU229505B1 (pl)
IL (2)	IL160166A0 (pl)
MX (1)	MXPA04002247A (pl)
NO (1)	NO328934B1 (pl)
NZ (1)	NZ531641A (pl)
PL (1)	PL224030B1 (pl)
PT (1)	PT1448567E (pl)
SI (1)	SI21463B (pl)
WO (1)	WO2003022853A1 (pl)
ZA (1)	ZA200401501B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60308695T2 (de) *	2002-06-27	2007-08-16	Smithkline Beecham Corp.	Herstellung von Stereoisomeren von (3Alpha,3alpha/beta,6alpha/beta) hexahydrofuro[2,3-b]furan-3-ol
EP1589018A4 (en) *	2002-12-27	2007-03-14	Sumitomo Chemical Co	METHOD OF PREPARING HEXAHYDROFUROFURANOL DERIVATIVES, INTERMEDIATE PRODUCTS AND MANUFACTURING METHOD THEREFOR
JP4818124B2 (ja)	2003-12-23	2011-11-16	テイボテク・フアーマシユーチカルズ・リミテツド	（３Ｒ，３ａＳ，６ａＲ）−ヘキサヒドロフロ〔２，３−ｂ〕フラン−３−イル（１Ｓ，１Ｒ）−３−〔〔（４−アミノフェニル）スルホニル〕（イソブチル）アミノ〕−１−ベンジル−２−ヒドロキシプロピルカルバマートの製造方法
TWI383975B (zh) *	2004-03-31	2013-02-01	悌柏泰克醫藥有限公司	製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
JP5549898B2 (ja) *	2006-03-31	2014-07-16	独立行政法人産業技術総合研究所	５−ヒドロキシメチル−２−フルフラールの製造法
CN102432621B (zh) *	2006-11-09	2016-02-17	爱尔兰詹森科学公司	六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
CN101024646B (zh) *	2007-02-06	2010-07-14	启东东岳药业有限公司	4-甲氧基呋喃并呋喃-2-酮的纯化方法
WO2008132154A1 (en)	2007-04-27	2008-11-06	Tibotec Pharmaceuticals Ltd.	Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
US8592487B2 (en)	2007-10-26	2013-11-26	Concert Pharmaceuticals, Inc.	Deuterated darunavir
TWI482775B (zh)	2008-09-01	2015-05-01	Tibotec Pharm Ltd	用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
WO2010047819A1 (en) *	2008-10-24	2010-04-29	Concert Pharmaceuticals, Inc.	Hydroxyethylamino sulfonamide derivatives
US8921415B2 (en)	2009-01-29	2014-12-30	Mapi Pharma Ltd.	Polymorphs of darunavir
WO2011051978A2 (en)	2009-10-30	2011-05-05	Lupin Limited	A novel process for preparation of darunavir and darunavir ethanolate of fine particle size
EP2528923B1 (en)	2010-01-28	2014-07-30	Mapi Pharma Limited	Process for the preparation of darunavir and darunavir intermediates
US8841467B2 (en)	2010-11-23	2014-09-23	Mylan Laboratories Limited	Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
WO2012075122A2 (en) *	2010-11-30	2012-06-07	Purdue Research Foundation	Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
EP3795572B1 (en)	2012-07-24	2023-11-15	Laurus Labs Limited	Darunavir propionate solvate
JPWO2014024898A1 (ja) *	2012-08-09	2016-07-25	住友化学株式会社	ヘキサヒドロフロフラノール誘導体の製造方法
CN103864813B (zh) *	2012-12-18	2017-02-22	上海迪赛诺化学制药有限公司	一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
US10633390B2 (en) *	2015-06-25	2020-04-28	Msn Laboratories Private Limited	Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form
WO2017041228A1 (zh) *	2015-09-08	2017-03-16	浙江九洲药业股份有限公司	六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN107043385B (zh) *	2016-02-05	2019-07-09	成都博腾药业有限公司	一种制备地瑞那韦中间体的方法
ES2881949T3 (es)	2016-10-27	2021-11-30	Gilead Sciences Inc	Forma cristalina de base libre de darunavir
CN106928248B (zh) *	2017-02-04	2019-01-04	青岛科技大学	一种制备(3R,3aS,6aR)六氢呋喃并[2,3-b]呋喃-3-醇的方法
CN116103348A (zh)	2018-03-16	2023-05-12	江苏瑞科医药科技有限公司	六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
US20240043438A1 (en) *	2020-08-11	2024-02-08	Arun K. Ghosh	Methods for making darunavir p2-ligand precursors
CN114853774A (zh) *	2022-06-24	2022-08-05	盐城迪赛诺制药有限公司	一种达卢那韦关键中间体的制备方法
CN115557964A (zh) *	2022-10-18	2023-01-03	启东东岳药业有限公司	一种药物化合物的制备方法
CN117186053A (zh) *	2023-09-08	2023-12-08	上海凌凯医药科技有限公司	一种莱克酮中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CU35543A1 (es) *	1980-10-09	1983-05-05	Hoffmann La Roche	Prostaglandines
NZ224497A (en) *	1987-05-18	1990-04-26	Janssen Pharmaceutica Nv	Pharmaceutical composition comprising flunarizine
US5281420A (en) *	1992-05-19	1994-01-25	The Procter & Gamble Company	Solid dispersion compositions of tebufelone
WO1994026749A1 (en) *	1993-05-14	1994-11-24	Merck & Co., Inc.	Hiv protease inhibitors
EP0715618B1 (en) *	1993-08-24	1998-12-16	G.D. Searle & Co.	Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
RU2089545C1 (ru) *	1994-09-28	1997-09-10	Ярославский государственный технический университет	Способ получения 2-метил-2-этил-1,3-диоксолан-4-ил-метилметакрилата
DE19510566A1 (de) *	1995-03-23	1996-09-26	Kali Chemie Pharma Gmbh	Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) *	1996-09-18	1998-03-19	Solvay Pharm Gmbh	Die gastrointestinale Durchblutung fördernde Arzneimittel
SK285019B6 (sk) *	1997-01-30	2006-04-06	Novartis Ag	Tvrdá želatínová tobolka
AU4828199A (en) *	1998-06-23	2000-01-10	Board Of Trustees Of The University Of Illinois, The	Multi-drug resistant retroviral protease inhibitors and associated methods
CA2872424C (en) *	1998-06-23	2017-03-07	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv
KR100336090B1 (ko) *	1998-06-27	2002-05-27	윤승원	오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) *	1999-02-16	2000-08-17	Solvay Pharm Gmbh	Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) *	1999-07-13	2001-01-18	Solvay Pharm Gmbh	Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
PL204924B1 (pl)	1999-10-06	2010-02-26	Tibotec Pharm Ltd	Heksahydrofuro [2,3-b] furanylo-3-N-{3(1,3-benzodioksolilo-5-sulfonylo) (izobutylo) amino] -1-benzylo-2-hydroksypropylo} karbaminian oraz jego zastosowanie

2002
- 2002-09-06 AP APAP/P/2004/002981A patent/AP1758A/en active
- 2002-09-06 PL PL367817A patent/PL224030B1/pl unknown
- 2002-09-06 BR BRPI0212341A patent/BRPI0212341B8/pt not_active IP Right Cessation
- 2002-09-06 EP EP02797968A patent/EP1448567B1/en not_active Expired - Lifetime
- 2002-09-06 KR KR1020047002113A patent/KR100894673B1/ko not_active Expired - Lifetime
- 2002-09-06 DE DE60234952T patent/DE60234952D1/de not_active Expired - Lifetime
- 2002-09-06 NZ NZ531641A patent/NZ531641A/en not_active IP Right Cessation
- 2002-09-06 US US10/489,059 patent/US7126015B2/en not_active Expired - Lifetime
- 2002-09-06 HR HRP20040320AA patent/HRP20040320B1/hr not_active IP Right Cessation
- 2002-09-06 CN CNB028176391A patent/CN100519561C/zh not_active Expired - Lifetime
- 2002-09-06 CN CN200710186668XA patent/CN101172980B/zh not_active Expired - Lifetime
- 2002-09-06 AT AT02797968T patent/ATE453648T1/de active
- 2002-09-06 PT PT02797968T patent/PT1448567E/pt unknown
- 2002-09-06 IL IL16016602A patent/IL160166A0/xx unknown
- 2002-09-06 MX MXPA04002247A patent/MXPA04002247A/es active IP Right Grant
- 2002-09-06 DK DK02797968.1T patent/DK1448567T3/da active
- 2002-09-06 SI SI200220026A patent/SI21463B/sl active Search and Examination
- 2002-09-06 HU HU0402140A patent/HU229505B1/hu unknown
- 2002-09-06 CA CA2459168A patent/CA2459168C/en not_active Expired - Lifetime
- 2002-09-06 AU AU2002333809A patent/AU2002333809C1/en not_active Expired
- 2002-09-06 WO PCT/EP2002/010062 patent/WO2003022853A1/en not_active Ceased
- 2002-09-06 JP JP2003526927A patent/JP4521185B2/ja not_active Expired - Lifetime
- 2002-09-06 ES ES02797968T patent/ES2338538T3/es not_active Expired - Lifetime
- 2002-09-06 EA EA200400430A patent/EA010883B1/ru not_active IP Right Cessation
- 2002-09-09 AR ARP020103403A patent/AR036501A1/es active IP Right Grant
2004
- 2004-02-02 IL IL160166A patent/IL160166A/en active IP Right Grant
- 2004-02-24 ZA ZA2004/01501A patent/ZA200401501B/en unknown
- 2004-04-06 NO NO20041434A patent/NO328934B1/no not_active IP Right Cessation
2010
- 2010-03-30 CY CY20101100296T patent/CY1109974T1/el unknown

Also Published As

Publication number	Publication date
CN101172980A (zh)	2008-05-07
SI21463B (sl)	2011-08-31
CA2459168C (en)	2014-01-28
AP2004002981A0 (en)	2004-03-31
MXPA04002247A (es)	2005-09-07
US20040249175A1 (en)	2004-12-09
EA010883B1 (ru)	2008-12-30
HRP20040320A2 (en)	2005-04-30
AR036501A1 (es)	2004-09-15
PT1448567E (pt)	2010-03-12
EP1448567B1 (en)	2009-12-30
IL160166A (en)	2012-05-31
SI21463A (sl)	2004-10-31
NZ531641A (en)	2005-08-26
WO2003022853A1 (en)	2003-03-20
JP4521185B2 (ja)	2010-08-11
EP1448567A1 (en)	2004-08-25
KR20040029425A (ko)	2004-04-06
AU2002333809B2 (en)	2008-02-28
PL224030B1 (pl)	2016-11-30
KR100894673B1 (ko)	2009-04-24
AU2002333809B8 (en)	2008-07-03
CA2459168A1 (en)	2003-03-20
CN1553915A (zh)	2004-12-08
IL160166A0 (en)	2004-07-25
DE60234952D1 (de)	2010-02-11
ZA200401501B (en)	2005-07-27
AU2002333809B9 (en)	2008-06-26
AP1758A (en)	2007-07-30
AU2002333809C1 (en)	2009-02-05
ES2338538T3 (es)	2010-05-10
NO328934B1 (no)	2010-06-21
HU229505B1 (hu)	2014-01-28
EA200400430A1 (ru)	2004-08-26
HUP0402140A3 (en)	2007-05-29
BRPI0212341B8 (pt)	2021-05-25
US7126015B2 (en)	2006-10-24
CN100519561C (zh)	2009-07-29
HUP0402140A2 (hu)	2005-02-28
HK1068887A1 (en)	2005-05-06
CN101172980B (zh)	2011-11-16
BRPI0212341B1 (pt)	2019-04-02
HRP20040320B1 (hr)	2012-11-30
DK1448567T3 (da)	2010-04-26
CY1109974T1 (el)	2014-09-10
NO20041434L (no)	2004-06-10
ATE453648T1 (de)	2010-01-15
JP2005502707A (ja)	2005-01-27
BR0212341A (pt)	2004-07-27

Publication	Publication Date	Title
IL160166A0 (en)	2004-07-25	Method for the preparation of hexahydro-furo[2,3-b] furan-3-ol
HUP0500109A3 (en)	2007-08-28	Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
PT1674456E (pt)	2008-09-11	Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas
ZA200507192B (en)	2007-03-28	Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
HUP0303590A3 (en)	2004-11-29	Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines
AU2003287038A1 (en)	2004-05-04	METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO (2, 3-b) FURAN AND RELATED COMPOUNDS
IL178019A0 (en)	2006-12-31	METHODS FOR THE PREPARATION OF (3R,3aS,6aR)HEXAHYDRO-FURO[2,3-b]FURAN-3OL
HU0103075D0 (en)	2001-10-28	Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one derivatives and intermediates thereof
AU5823901A (en)	2001-11-20	Method for the preparation of citalopram
IL142630A0 (en)	2002-03-10	FUNGICIDAL COMBINATIONS COMPRISING THIENO [2,3-d] PYRIMIDIN-4-ONE
AU6259701A (en)	2002-01-02	Process for the preparation of pyrazolopyrimidinones
HUP0402475A3 (en)	2008-10-28	Process for the preparation of [1,4,5]-oxadiazepine derivatives
AU2001272368A1 (en)	2002-01-21	Method for the preparation of citalopram
HUP0401991A3 (en)	2005-11-28	Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
PL361914A1 (pl)	2004-10-04	Sposób otrzymywania pochodnej pirazolo [4,3-D] pirymidyny
HK1065035A (en)	2005-02-08	4-thioxo-4, 7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
AU2002249279A1 (en)	2002-10-21	Method for the production of 6-aryl-4h-s-triazolo(3,4-c)-thieno(2,3-e)-1,4-diazepines
HU0003960D0 (en)	2000-12-28	Process for the preparation of sulphonyl-pyridyl-pyrazolo[4,3-d]pyrimidin-7-one derivatives and intermediates
AU2002317106A1 (en)	2003-01-21	Process for the preparation of tetrahydrothieno (3,2-c) pyridine derivatives
AU2002307501A1 (en)	2002-11-05	Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino(2,3-b)pyridine
AU2002327568A1 (en)	2003-03-18	4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carboxamides as ant iviral agents
AU2002323523A1 (en)	2003-03-18	4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carbothioamides as antiviral agents
AU2002331567A1 (en)	2003-03-18	4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carbothioamides as antiviral agents
GB0107526D0 (en)	2001-05-16	Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
HK1066803A (en)	2005-04-01	Synthesis of 4,5-dihydro-pyrazolo (3,4-c) pyrid-2-ones